» Articles » PMID: 11712095

Biochemical Characterization of a Virus Isolate, Recovered from a Patient with Herpes Keratitis, That Was Clinically Resistant to Acyclovir

Overview
Journal Clin Infect Dis
Date 2001 Nov 17
PMID 11712095
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro susceptibility assays of herpes simplex virus (HSV) do not necessarily correlate with treatment outcome. An HSV type 1 (HSV-1) isolate, N4, recovered from a patient who presented with herpes keratitis with localized immunosuppression, was characterized for susceptibility. Although the 50% inhibitory concentration (IC(50)) for this isolate was less than the accepted breakpoint for defining resistance to acyclovir (>2.0 microg/mL), the following lines of evidence suggest that the isolate was acyclovir resistant: (1) the clinical history confirmed that the infection was nonresponsive to acyclovir; (2) the in vitro susceptibility was similar to that of a thymidine kinase (TK)-negative, acyclovir-resistant virus SLU360; (3) the IC(50) of acyclovir was more than 10 times the IC(50) for an acyclovir-susceptible control strain; (4) plaque-purified clonal isolates were resistant to acyclovir (IC(50)s, >2.0 microg/mL); and (5) biochemical studies indicated that the HSV-1 N4 TK was partially impaired for acyclovir phosphorylation. Although residue changes were found in both the viral tk and pol coding regions of HSV-1 N4, characterization of a recombinant virus expressing the HSV-1 N4 polymerase suggested that the TK and Pol together conferred the acyclovir-resistance phenotype.

Citing Articles

The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.

Antony F, Kinha D, Nowinska A, Rouse B, Suryawanshi A Clin Microbiol Rev. 2024; 37(3):e0000624.

PMID: 39078136 PMC: 11391706. DOI: 10.1128/cmr.00006-24.


Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.

Houston D, Bugert J, Denyer S, Heard C PLoS One. 2017; 12(6):e0179291.

PMID: 28665969 PMC: 5493292. DOI: 10.1371/journal.pone.0179291.


A Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies.

Fabiani M, Limongi D, Palamara A, De Chiara G, Marcocci M Front Microbiol. 2017; 8:1085.

PMID: 28659899 PMC: 5469900. DOI: 10.3389/fmicb.2017.01085.


Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Piret J, Boivin G Antimicrob Agents Chemother. 2010; 55(2):459-72.

PMID: 21078929 PMC: 3028810. DOI: 10.1128/AAC.00615-10.


Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.

Bacon T, Levin M, Leary J, Sarisky R, Sutton D Clin Microbiol Rev. 2003; 16(1):114-28.

PMID: 12525428 PMC: 145299. DOI: 10.1128/CMR.16.1.114-128.2003.